Semaglutide
GLP-1 receptor agonist widely used for weight management and metabolic health
Clinical Research Score: 5/5 — FDA-approved (Ozempic/Wegovy) with large randomized controlled trials such as the STEP program demonstrating significant weight loss.
Categories: Weight Loss / Metabolic
What is Semaglutide?
Semaglutide changed the weight loss landscape forever. People who have struggled with their weight for decades — tried every diet, every program — report losing 10-15% of their total body weight, often for the first time in their lives. But the number on the scale is only part of the story.
The most life-changing benefit people describe is the silencing of "food noise" — that constant background hum of thinking about your next meal, craving snacks, negotiating with yourself about dessert. It simply goes quiet. People describe feeling neutral about food for the first time, eating because their body needs fuel rather than being driven by cravings.
Blood sugar stabilizes. Energy becomes more consistent throughout the day. The relationship with food fundamentally shifts from emotional and compulsive to calm and rational. For many, it's not just a weight loss tool — it's the reset button they've been waiting for.
How Semaglutide works
Semaglutide mimics GLP-1, a natural hormone your gut releases after eating. It tells your brain you're full, slows down how fast food leaves your stomach (so you feel satisfied longer), and helps your body regulate blood sugar more effectively. The key difference from natural GLP-1 is that semaglutide lasts for days instead of minutes, providing continuous appetite control around the clock.
Scientific overview
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the incretin hormone GLP-1. It works by stimulating insulin secretion, suppressing glucagon release, slowing gastric emptying, and acting on brain centers that regulate appetite and food intake. Originally developed for type 2 diabetes management, it has shown remarkable efficacy in weight management studies.
Dosing
- Starting dose: 0.25 mg per week
- Common dosage range: 0.25-2.4 mg per week (titrated up)
- Administration: Subcutaneous
- Half-life: ~7 days
- Frequency: 1x per week